A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Peethambaram PP, Melisko ME, Rinn KJ, Alberts SR, Provost NM, Jones LA, Sims RB, Lin LR, Frohlich MW, Park JW

Publication

Clinical cancer research : an official journal of the American Association for Cancer Research

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1470285

Publication Year

2009

PubMed ID

19723649

Publication Title

Peethambaram PP, Melisko ME, Rinn KJ, Alberts SR, Provost NM, Jones LA, Sims RB, Lin LR, Frohlich MW, Park JW. A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu. Clin Cancer Res. 2009 Sep 15; 15(18):5937-44.